Patent details
EP3506907 Title: COMBINATION CANCER THERAPY WITH A PENTAAZA MACROCYCLIC RING COMPLEX AND AN ASCORBATE COMPOUND
Basic Information
- Publication number:
- EP3506907
- PCT Application Number:
- US2017049960
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP178476594
- PCT Publication Number:
- WO2018045348
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- COMBINATION CANCER THERAPY WITH A PENTAAZA MACROCYCLIC RING COMPLEX AND AN ASCORBATE COMPOUND
- French Title of Invention:
- POLYTHÉRAPIE ANTICANCÉREUSE AVEC UN COMPLEXE D'UN CYCLE MACROCYCLIQUE PENTAAZA ET UN COMPOSÉ ASCORBATE
- German Title of Invention:
- KOMBINIERTE KREBSTHERAPIE MIT EINEM PENTAAZA-MAKROCYCLISCHEN RING-KOMPLEX UND EINER ASCORBATVERBINDUNG
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 05/07/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 17/07/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 07/06/2023
- Unitary Effect Registration Date:
- 17/07/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 01/09/2017
- Grant date:
- 07/06/2023
- EP Publication Date:
- 10/07/2019
- PCT Publication Date:
- 08/03/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/06/2023
- EP B1 Publication Date:
- 07/06/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 01/09/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 31/05/2023
- Name:
- Galera Labs, LLC
- Address:
- 1100 Corporate Square Drive, Suite 223, Creve Coeur, Missouri 63132, United States (US)
Inventor
1
- Name:
- FATH, Melissa A.
- Address:
- United States (US)
2
- Name:
- SPITZ, Douglas R., JR.
- Address:
- United States (US)
3
- Name:
- RILEY, Dennis P.
- Address:
- United States (US)
4
- Name:
- BEARDSLEY, Robert A.
- Address:
- United States (US)
5
- Name:
- HEER, Collin
- Address:
- United States (US)
Priority
- Priority Number:
- 201662382667 P
- Priority Date:
- 01/09/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/555; A61K 31/375; A61K 31/714; A61K 31/16; A61K 31/198; A61K 31/635; A61K 31/7135; A61K 33/32; A61K 45/06; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202323
- Publication date:
- 07/06/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202333
- Publication date:
- 16/08/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|